The JAK/STAT signaling pathway is involved in various cellular mechanisms, such as proliferation, apoptosis, and inflammation [22], and the JAK1/2-inhibitor Bar reduces the expression of proinflammatory genes in HGPS cells [12]. This evidence concerns the gene SOAT1 and Hutchinson-Gilford progeria syndrome.